Prevalence of Neuroradiological Abnormalities in First-Episode Psychosis: A Systematic Review and Meta-analysis
- PMID: 37436735
- PMCID: PMC10339221
- DOI: 10.1001/jamapsychiatry.2023.2225
Prevalence of Neuroradiological Abnormalities in First-Episode Psychosis: A Systematic Review and Meta-analysis
Abstract
Importance: Individuals presenting with first-episode psychosis (FEP) may have a secondary ("organic") etiology to their symptoms that can be identified using neuroimaging. Because failure to detect such cases at an early stage can have serious clinical consequences, it has been suggested that brain magnetic resonance imaging (MRI) should be mandatory for all patients presenting with FEP. However, this remains a controversial issue, partly because the prevalence of clinically relevant MRI abnormalities in this group is unclear.
Objective: To derive a meta-analytic estimate of the prevalence of clinically relevant neuroradiological abnormalities in FEP.
Data sources: Electronic databases Ovid, MEDLINE, PubMed, Embase, PsychINFO, and Global Health were searched up to July 2021. References and citations of included articles and review articles were also searched.
Study selection: Magnetic resonance imaging studies of patients with FEP were included if they reported the frequency of intracranial radiological abnormalities.
Data extraction and synthesis: Independent extraction was undertaken by 3 researchers and a random-effects meta-analysis of pooled proportions was calculated. Moderators were tested using subgroup and meta-regression analyses. Heterogeneity was evaluated using the I2 index. The robustness of results was evaluated using sensitivity analyses. Publication bias was assessed using funnel plots and Egger tests.
Main outcomes and measures: Proportion of patients with a clinically relevant radiological abnormality (defined as a change in clinical management or diagnosis); number of patients needed to scan to detect 1 such abnormality (number needed to assess [NNA]).
Results: Twelve independent studies (13 samples) comprising 1613 patients with FEP were included. Of these patients, 26.4% (95% CI, 16.3%-37.9%; NNA of 4) had an intracranial radiological abnormality, and 5.9% (95% CI, 3.2%-9.0%) had a clinically relevant abnormality, yielding an NNA of 18. There were high degrees of heterogeneity among the studies for these outcomes, 95% to 73%, respectively. The most common type of clinically relevant finding was white matter abnormalities, with a prevalence of 0.9% (95% CI, 0%-2.8%), followed by cysts, with a prevalence of 0.5% (95% CI, 0%-1.4%).
Conclusions and relevance: This systematic review and meta-analysis found that 5.9% of patients presenting with a first episode of psychosis had a clinically relevant finding on MRI. Because the consequences of not detecting these abnormalities can be serious, these findings support the use of MRI as part of the initial clinical assessment of all patients with FEP.
Conflict of interest statement
Figures
Comment in
-
Beyond the AJR: Should Patients With First-Episode Psychosis Undergo Brain MRI?AJR Am J Roentgenol. 2024 Jun;222(6):e2330338. doi: 10.2214/AJR.23.30338. Epub 2024 Jun 5. AJR Am J Roentgenol. 2024. PMID: 37818960 No abstract available.
-
Concerns Regarding Strength of Conclusions in Systematic Review and Meta-Analysis of Neuroradiological Abnormalities in First-Episode Psychosis.JAMA Psychiatry. 2024 Jan 1;81(1):107. doi: 10.1001/jamapsychiatry.2023.4390. JAMA Psychiatry. 2024. PMID: 37966810 No abstract available.
-
Concerns Regarding Strength of Conclusions in Systematic Review and Meta-Analysis of Neuroradiological Abnormalities in First-Episode Psychosis.JAMA Psychiatry. 2024 Jan 1;81(1):108. doi: 10.1001/jamapsychiatry.2023.4393. JAMA Psychiatry. 2024. PMID: 37966820 No abstract available.
-
Concerns Regarding Strength of Conclusions in Systematic Review and Meta-Analysis of Neuroradiological Abnormalities in First-Episode Psychosis.JAMA Psychiatry. 2024 Jan 1;81(1):107-108. doi: 10.1001/jamapsychiatry.2023.4396. JAMA Psychiatry. 2024. PMID: 37966834 No abstract available.
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Neuroimaging for the evaluation of chronic headaches: an evidence-based analysis.Ont Health Technol Assess Ser. 2010;10(26):1-57. Epub 2010 Dec 1. Ont Health Technol Assess Ser. 2010. PMID: 23074404 Free PMC article.
-
Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis.Psychoneuroendocrinology. 2023 Apr;150:106049. doi: 10.1016/j.psyneuen.2023.106049. Epub 2023 Feb 4. Psychoneuroendocrinology. 2023. PMID: 36758330 Review.
-
Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification.JAMA Psychiatry. 2016 Feb;73(2):113-20. doi: 10.1001/jamapsychiatry.2015.2324. JAMA Psychiatry. 2016. PMID: 26719911
-
Structural neuroimaging in psychosis: a systematic review and economic evaluation.Health Technol Assess. 2008 May;12(18):iii-iv, ix-163. doi: 10.3310/hta12180. Health Technol Assess. 2008. PMID: 18462577 Review.
Cited by
-
An exploratory study of the damage markers NfL, GFAP, and t-Tau, in cerebrospinal fluid and other findings from a patient cohort enriched for suspected autoimmune psychiatric disease.Transl Psychiatry. 2024 Jul 24;14(1):304. doi: 10.1038/s41398-024-03021-8. Transl Psychiatry. 2024. PMID: 39048548 Free PMC article.
-
Neuroimaging education in psychiatric training.Neuropsychopharmacology. 2024 Nov;50(1):298-304. doi: 10.1038/s41386-024-01909-z. Epub 2024 Jul 18. Neuropsychopharmacology. 2024. PMID: 39025952 Review.
-
Diagnostic Transitions from Primary Psychiatric Disorders to Underlying Medical Conditions: A 5-Year Retrospective Survey from a University Hospital Sample.Alpha Psychiatry. 2024 Mar 1;25(2):226-232. doi: 10.5152/alphapsychiatry.2024.231274. eCollection 2024 Mar. Alpha Psychiatry. 2024. PMID: 38798811 Free PMC article.
-
Schizencephaly Associated With Bipolar Affective Disorder.Cureus. 2024 Feb 20;16(2):e54534. doi: 10.7759/cureus.54534. eCollection 2024 Feb. Cureus. 2024. PMID: 38516433 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
